|
?:authorAffiliation
|
-
[\'Pharmaceutical Biotechnology, Eberhard Karls University, Tuebingen, Germany.\', \'Natural and Medical Sciences Institute, University of Tuebingen, Reutlingen, Germany.\', \'Interfaculty Institute of Biochemistry, Eberhard Karls University, Tuebingen, Germany.\', \'Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Tuebingen, Germany.\', \'Livestock Center of the Faculty of Veterinary Medicine, Ludwig Maximilians University, Oberschleissheim, Germany.\', \'Cluster of Excellence iFIT (EXC2180) \'Image-Guided and Functionally Instructed Tumor Therapies\', Eberhard Karls University, Tuebingen, Germany.\', \'Department of Women\'s Health, Research Institute for Women\'s Health, Eberhard Karls University, Tuebingen, Germany.\', \'Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.\', \'Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany.\', \'Institute for Cell Biology, Department of Immunology, Eberhard Karls University, Tuebingen, Germany.\', \'Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.\', \'TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, A Joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany.\', \'Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology and Robert Bosch Center for Tumor Disease, RBCT, Stuttgart, Germany.\', \'Vanderbilt University School of Medicine, Nashville, TN, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}